216 related articles for article (PubMed ID: 19335780)
1. Obesity management in liver clinics: what's your style of lifestyle intervention?
Hickman IJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):327-8. PubMed ID: 19335780
[No Abstract] [Full Text] [Related]
2. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
[TBL] [Abstract][Full Text] [Related]
3. Identification of appropriate patients for cardiometabolic risk management.
Peters AL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
[TBL] [Abstract][Full Text] [Related]
4. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
5. Self-reported health-related behaviors and dietary habits in patients with metabolic syndrome.
Piotrowicz K; Pałkowska E; Bartnikowska E; Krzesiński P; Stańczyk A; Biecek P; Skrobowski A; Gielerak G
Cardiol J; 2015; 22(4):413-20. PubMed ID: 26325258
[TBL] [Abstract][Full Text] [Related]
6. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.
Grønbæk H; Lange A; Birkebæk NH; Holland-Fischer P; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):223-8. PubMed ID: 21760546
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome and cardiovascular disease: part 2.
Jiamsripong P; Mookadam M; Alharthi MS; Khandheria BK; Mookadam F
Prev Cardiol; 2008; 11(4):223-9. PubMed ID: 19476575
[TBL] [Abstract][Full Text] [Related]
8. Risk factor management: a practice guide.
Perk J
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
[No Abstract] [Full Text] [Related]
9. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
10. The cardiovascular prevention and lifestyle quiz for cardiologists.
De Sutter J; Conraads VM
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S8-10. PubMed ID: 19675443
[No Abstract] [Full Text] [Related]
11. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
12. [Non-alcoholic fatty liver disease and cardiovascular risk].
Abel T; Fehér J
Orv Hetil; 2008 Jul; 149(28):1299-305. PubMed ID: 18617457
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the "typical" cardiometabolic patient for risk of cardiovascular disease.
Strobl DJ
J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S21-2. PubMed ID: 19451255
[No Abstract] [Full Text] [Related]
14. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
15. Optimal treatments for the metabolic syndrome.
Giugliano D; Esposito K
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):e30. PubMed ID: 16556857
[No Abstract] [Full Text] [Related]
16. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
Boppidi H; Daram SR
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
[TBL] [Abstract][Full Text] [Related]
17. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
Després JP
Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
[No Abstract] [Full Text] [Related]
18. [Non-alcoholic fatty liver disease and steatohepatitis].
Pár G; Horváth G; Pár A
Orv Hetil; 2013 Jul; 154(29):1124-34. PubMed ID: 23853345
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of non-alcoholic fatty liver disease].
Koek GH
Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
